Location History:
- Ebergoetzen, DE (2015 - 2020)
- Ebergötzen, DE (2020)
Company Filing History:
6 out of 300 
1 out of 6,158 
Years Active: 2015-2024
Title: Thomas Krumbein: Innovator in Biopharmaceutical Device Arrangements
Introduction
Thomas Krumbein is a notable inventor based in Ebergoetzen, Germany. He has made significant contributions to the field of biopharmaceutical processes, holding a total of seven patents. His work focuses on developing innovative device arrangements that enhance the efficiency and effectiveness of biopharmaceutical operations.
Latest Patents
One of Krumbein's latest patents is a configurable device arrangement for performing at least one unit operation in a biopharmaceutical process. This invention includes a base rack and multiple holders for the releasable direct or indirect attachment of process components, particularly single-use components. The holders are designed to be easily attached to the base rack, and the device arrangement features a positioning system that defines specific positions for the holders relative to the base rack. Another notable patent is the filter cassette, which further showcases his innovative approach to biopharmaceutical technology.
Career Highlights
Throughout his career, Krumbein has worked with prominent companies in the industry. He has been associated with Sartorius Stedim Biotech GmbH, a leader in biopharmaceutical manufacturing solutions, and Sumitomo Wiring Systems, Limited, which specializes in wiring harnesses and related products. His experience in these organizations has contributed to his expertise in developing advanced biopharmaceutical devices.
Collaborations
Krumbein has collaborated with several professionals in his field, including Stefan Weisshaar and Michael Bates. These partnerships have allowed him to enhance his inventions and contribute to the advancement of biopharmaceutical technologies.
Conclusion
Thomas Krumbein is a distinguished inventor whose work in biopharmaceutical device arrangements has made a significant impact on the industry. His innovative patents and collaborations reflect his commitment to advancing biopharmaceutical processes.